0001209191-22-041149.txt : 20220706
0001209191-22-041149.hdr.sgml : 20220706
20220706163611
ACCESSION NUMBER: 0001209191-22-041149
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220701
FILED AS OF DATE: 20220706
DATE AS OF CHANGE: 20220706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wassil Jim
CENTRAL INDEX KEY: 0001813798
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39323
FILM NUMBER: 221069243
MAIL ADDRESS:
STREET 1: C/O VAXCYTE, INC.
STREET 2: 353 HATCH DRIVE
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxcyte, Inc.
CENTRAL INDEX KEY: 0001649094
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 464233385
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD, STE. 300
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-837-0111
MAIL ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD, STE. 300
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
FORMER COMPANY:
FORMER CONFORMED NAME: SutroVax, Inc.
DATE OF NAME CHANGE: 20150724
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-01
0
0001649094
Vaxcyte, Inc.
PCVX
0001813798
Wassil Jim
C/O VAXCYTE, INC.
825 INDUSTRIAL ROAD, STE. 300
SAN CARLOS
CA
94070
0
1
0
0
Chief Operating Officer
Common Stock
2022-07-01
4
M
0
2800
2.42
A
47306
D
Common Stock
2022-07-01
4
S
0
2800
22.00
D
44506
D
Stock Option (right to buy)
2.42
2022-07-01
4
M
0
2800
0.00
D
2029-12-16
Common Stock
2800
230326
D
Includes 1,562 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2022.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter.
Jim Wassil, by /s/ Ron A. Metzger, Attorney-in-Fact
2022-07-06